# An Comparative Pharmacokinetic Study of Amlodipine Besylate Controlled-release Tablets,China in Normal, Healthy, Adult, Human Subjects Under Fasting Conditions

> **NCT05667818** · PHASE1 · UNKNOWN · sponsor: **Overseas Pharmaceuticals, Ltd.** · enrollment: 16 (estimated)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Amlodipine besylate tablets (trade name: Norfloxacin ®）
- **DRUG:** Amlodipine besylate controlled-release tablets

## Key facts

- **NCT ID:** NCT05667818
- **Lead sponsor:** Overseas Pharmaceuticals, Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-01-28
- **Primary completion:** 2023-02-28
- **Final completion:** 2023-03-10
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2023-01-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05667818

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05667818, "An Comparative Pharmacokinetic Study of Amlodipine Besylate Controlled-release Tablets,China in Normal, Healthy, Adult, Human Subjects Under Fasting Conditions". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05667818. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*